Cancer and the Immune System: Basic Concepts and Targets for Intervention

Seminars in Oncology
Drew M Pardoll

Abstract

A number of consensuses regarding cancer immunology have recently emerged from both preclinical immunotherapy models and analysis of cancer patients. First and foremost, the natural state of endogenous tumor reactive T cells is characterized by general hyporesponsiveness or anergy. This is likely due to a number of mechanisms that tumors use to induce tolerance as they develop. While many of the newer generation vaccines can effectively transfer antigen to and activate dendritic cells, T-cell tolerance remains a major barrier that is difficult to overcome by vaccination alone. Preclinical models demonstrate that for poorly immunogenic tumors, once tolerance has been established, therapeutic vaccines alone are ineffective at curing animals with a significant established tumor burden. However, combination strategies of vaccination together with inhibitors of immunologic checkpoints and agonists for co-stimulatory pathways are proving capable of overcoming tolerance and generating significant anti-tumor responses even in cases of established metastatic cancer.

References

Jan 1, 1976·Transplantation Reviews·J Rygaard, C O Povlsen
Oct 1, 1992·Current Opinion in Oncology·G Gaidano, R Dalla-Favera
Sep 1, 1991·The Journal of Experimental Medicine·P S LinsleyJ A Ledbetter
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Nov 4, 1993·Nature·M AzumaC Somoza
Jan 1, 1996·Annual Review of Immunology·D J LenschowJ A Bluestone
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·K Staveley-O'CarrollH Levitsky
Jul 22, 1998·Journal of Immunotherapy·Y KawakamiS A Rosenberg
Apr 3, 2001·The Journal of Experimental Medicine·S Y TsengH Tsuchiya
Feb 21, 2002·The Journal of Experimental Medicine·Linh T NguyenPamela S Ohashi
Nov 26, 2002·Immunological Reviews·Pierre Van Der BruggenThierry Boon
Jul 16, 2004·The Journal of Clinical Investigation·David H MunnAndrew L Mellor
Dec 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·R Houston ThompsonEugene D Kwon
May 11, 2005·The Journal of Experimental Medicine·Anne M ErcoliniElizabeth M Jaffee
Jul 28, 2005·Cancer Immunology, Immunotherapy : CII·Sergei Kusmartsev, Dmitry I Gabrilovich
Sep 2, 2005·Nature·Gerald Willimsky, Thomas Blankenstein
Nov 16, 2005·Nature Immunology·Chen ZhuVijay K Kuchroo
Aug 15, 2006·Immunological Reviews·Shimon SakaguchiTakashi Nomura
Aug 26, 2006·Science·Helga SchneiderChristopher E Rudd
Sep 9, 2006·Science·Tobias SjöblomVictor E Velculescu
Oct 26, 2006·Nature Reviews. Immunology·Gavin P DunnRobert D Schreiber
Dec 23, 2006·Nature Reviews. Immunology·Hua YuDrew Pardoll
Feb 27, 2007·Cell·Peter A Jones, Stephen B Baylin
May 16, 2007·The Journal of Experimental Medicine·Silvia DeaglioSimon C Robson
Oct 13, 2007·The Journal of Clinical Investigation·Joseph F GrossoCharles G Drake
Dec 21, 2007·European Journal of Immunology·Helga SchneiderChristopher E Rudd

❮ Previous
Next ❯

Citations

Jan 3, 2016·Current Opinion in Immunology·Alistair M CookRichard A Lake
Mar 13, 2016·Medical Hypotheses·Vladimir Kalina, David J Kopsky
Jan 30, 2016·Nature Reviews. Cancer·Nicholas P RestifoAlexandra Snyder
Mar 13, 2016·Seminars in Oncology·Malgorzata E WojtowiczAsad Umar
Jan 3, 2016·Cancer Letters·Kelly FoleyLei Zheng
Apr 16, 2016·Nature Reviews. Cancer·Suzanne L TopalianDrew M Pardoll
May 26, 2016·Expert Opinion on Biological Therapy·Myrna R Nahas, David Avigan
May 3, 2016·Human Vaccines & Immunotherapeutics·Arun RajanJames L Gulley
Jun 25, 2016·Cancer Cell International·Himani GargShweta Dubey
Aug 9, 2016·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ilinca PoppDan G Duda
Oct 5, 2016·Advances in Biological Regulation·Isabel MéridaRaquel Arcos
Nov 22, 2016·International Journal of Molecular Sciences·Yan Cui, Gang Guo
Apr 4, 2017·Current Opinion in Neurology·David A ReardonJohn H Sampson
May 22, 2016·Integrative Cancer Therapies·Maurice OrangeUwe Hobohm
Oct 20, 2018·Gut Microbes·Arielle ElkriefBertrand Routy
Dec 5, 2018·Journal of Cellular Physiology·Sanam SadreddiniLeili Aghebati-Maleki
Feb 21, 2019·Journal of Cellular Physiology·Amir Salek FarrokhiMajid Eslami
Mar 12, 2019·Expert Opinion on Biological Therapy·Gerhard Hamilton, Barbara Rath
Aug 23, 2018·Virchows Archiv : an International Journal of Pathology·Thomas Menter, Alexandar Tzankov
Feb 5, 2016·Journal of Cancer Research and Clinical Oncology·Elias KotteasKonstantinos Syrigos
Feb 15, 2020·Annals of Neurology·Peter AlpingThomas Frisell
Oct 23, 2019·Journal of Translational Internal Medicine·Katrin Sak
Sep 5, 2019·Cell Research·Nicolas JacquelotLaurence Zitvogel
Jul 9, 2020·Scandinavian Journal of Immunology·Anna K Winge-MainElse Marit Inderberg
Jan 7, 2017·Cold Spring Harbor Symposia on Quantitative Biology·Thorsten BergerTak W Mak
Feb 25, 2017·Nature Reviews. Cancer·Mark YarchoanElizabeth M Jaffee
Oct 28, 2018·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Mark E GrayDavid Argyle
Dec 1, 2016·Lung Cancer Management·Surein ArulanandaThomas John
Nov 27, 2019·Biomolecules·Shonia SubramaniamAmmu Kutty Radhakrishnan
Aug 15, 2020·Frontiers in Cell and Developmental Biology·Qingyang LeiYi Zhang
Sep 25, 2020·Asia-Pacific Journal of Clinical Oncology·Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares
Dec 1, 2015·Veterinary Sciences·Daniel Regan, Steven Dow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.